Alvotech (ALVO) Share-based Compensation (IS) (2025 - 2026)
Alvotech's Share-based Compensation (IS) came in at $660.69 million for Q1 2026, down 66.8% from the prior quarter.
Analysis
Alvotech (ALVO) Share-based Compensation (IS) (2025 - 2026) Analysis & Trends
For FY2025, Alvotech's Share-based Compensation (IS) was $1.99 billion.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | - |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | - |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Alvotech | 1.35 Bn | 919.66 Mn | 2.56 Mn | - |
API Access
Alvotech Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ALVO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ALVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ALVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();